R--NHLBI Internal Communication Services
ID: 75N92024Q1125Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Marketing Consulting Services (541613)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/41fc55e17f244fd18d30a5268b340cac/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), is seeking information from qualified business sources for its Internal Communication Services requirement through a Sources Sought notice. This notice aims to gather insights on the availability and capabilities of potential vendors to assist in determining the appropriate acquisition method, including the possibility of a set-aside. The services sought are crucial for enhancing internal communication within the NHLBI, which plays a vital role in public health and research initiatives. Interested parties can reach out to Melanie Suarez at melanie.peel@nih.gov or call 301-435-0330 for further details, as this is not a solicitation for proposals at this stage.

    Point(s) of Contact
    Suarez, Melanie
    (301) 435-0330
    melanie.peel@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    R--NHLBI Internal Communication Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Biological Therapeutics Product Development Subject Matter Expert Consultants
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for consulting services from subject matter expert (SME) consultants to support the development of biological therapeutics. The primary objective is to engage experts who can provide technical recommendations across various phases of drug discovery and development, including chemistry, regulatory affairs, and clinical trial design, particularly for novel therapeutics aimed at neurological disorders and rare genetic conditions. This initiative is crucial for advancing NIH's drug discovery programs, ensuring that innovative biologics progress efficiently through clinical evaluation. Interested vendors should note that the contract has a performance period of one year, with two optional extensions, and proposals must be submitted by January 27, 2025. For further inquiries, potential bidders can contact Shayna Simpson at shayna.simpson@nih.gov or Kelly Dempsey at kelly.dempsey@nih.gov.
    Q--Jackson Heart Study Whole Genome Sequencing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the Jackson Heart Study Whole Genome Sequencing project. This initiative aims to conduct comprehensive whole genome sequencing to enhance understanding of cardiovascular health within the Jackson Heart Study cohort. The services procured will play a crucial role in advancing medical research and improving health outcomes related to heart disease. Interested parties can reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details regarding the presolicitation notice.
    NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Special Notice regarding a subcontract opportunity at the Frederick National Laboratory for Cancer Research (FNLCR) aimed at enhancing laboratory practices to meet Good Clinical Laboratory Practice (GCLP) standards. The primary objective is to engage a subcontractor to evaluate current laboratory operations, identify compliance gaps, and implement improvements related to sample management, data integrity, and overall laboratory quality standards. This initiative is crucial for ensuring the integrity of testing and data management, which will facilitate the approval of new vaccine recommendations and enhance the laboratory's quality management system. Interested parties should note that this notice is for informational purposes only, with responses treated as government property, and are encouraged to monitor SAM.gov for updates. The deadline for submissions is January 3, 2025, at noon EST, and inquiries can be directed to Jennifer Gnuschke at jennifer.gnuschke@nih.gov.
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for the Liver Cirrhosis Network
    Active
    Health And Human Services, Department Of
    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF seeks industry partners for clinical research collaborations on therapeutics, diagnostics or devices for the Liver Cirrhosis Network. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is looking for industry collaborators to provide novel or repurposed therapeutic agents, diagnostic markers, biomarkers, devices, or services for use in NIH-sponsored multi-center clinical trials and ancillary studies in adult patients with advanced liver disease and cirrhosis. The Liver Cirrhosis Network aims to promote clinical and translational research on cirrhosis of the liver and related complications in adults. The network is interested in conducting research that will lead to improved clinical outcomes in adults with cirrhosis and advanced liver disease. Commercial organizations interested in pursuing clinical collaborations with NIDDK for cirrhosis liver disease are required to submit a Capability Statement to the NIDDK.
    Notice of Intent to Sole Source – Articulate Global
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Articulate Global, LLC for the renewal of licenses for the Articulate 360 suite of e-learning authoring tools. This procurement aims to provide the NIH Clinical Center Nursing Department with continued access to a suite of customizable tools essential for developing and maintaining over 60 online courses that have been created since 2015. The renewal is critical as it allows the Nursing Department to efficiently update existing courses without the need to transition to a new vendor, which would significantly disrupt their operations. Interested parties may express their interest and capabilities by contacting Kristin Nagashima, Contract Specialist, via email at Kristin.nagashima@nih.gov by January 17, 2025, at 5 PM EST.
    Fire Annunciation and Suppression Maintenance and Repair Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide Fire Annunciation and Suppression Maintenance and Repair Services for the National Institute of Environmental Health Sciences (NIEHS) located in Durham, North Carolina. The procurement includes preventive maintenance, emergency repairs, inspections, new installations, and programming for the SimplexGrinnell fire annunciator and fire suppression systems at the NIEHS Main Campus and an additional facility. This opportunity is critical for ensuring the safety and operational readiness of fire safety systems within NIH facilities. Interested vendors must submit a Capability Statement by January 10, 2025, and must be registered in the System for Award Management (SAM). For further inquiries, contact Andrew Gathogo at andrew.gathogo@nih.gov or call 984-287-4386.
    A--Clinical Research Operations and Management (CROMS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the Clinical Research Operations and Management Services (CROMS) contract. This procurement aims to enhance the oversight and efficiency of clinical studies by providing essential systems, tools, and expert resources for data management, site monitoring, and regulatory compliance. The contract is crucial for ensuring high-quality research while adhering to strict federal regulations regarding human subjects, data privacy, and security protocols. The performance period is set from September 30, 2025, to September 29, 2026, with options extending through 2030. Interested parties can reach out to Natalie Bruning at natalie.bruning@nih.gov or Tara C. Knox at knoxt@nhlbi.nih.gov for further details.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.